Strata Oncology is a leading brand in precision oncology, revolutionizing cancer care with their innovative approach. Their mission is to provide smarter and earlier treatment options for cancer patients to ensure the best possible therapy for each individual. With their flagship product, Strata Select™, they offer a first-of-its-kind molecular profiling test that personalizes immunotherapy with a simple score for all solid tumors.

This test provides treatment selection guidance for immunotherapy and beyond, and it is even covered by Medicare. Strata Oncology's vision for precision-matched treatment is focused on treatment selection across therapeutic modalities through quantitative RNA expression and multivariate predictive biomarkers. They are committed to bringing new options to patients with cancer through their suite of innovative clinical trials, advancing precision treatment hypotheses for both late-stage and early-stage disease to improve outcomes and utilization.

Strata Oncology serves a wide range of customers across the healthcare ecosystem, including providers, health systems, and biopharma partners, helping them deliver optimal precision cancer care, drive better outcomes, and accelerate drug development. Join the movement and experience the future of cancer care with Strata Oncology